Sachiko Imamura

Dr. Sachiko Imamura

Tsumura Kampo Research Laboratories, Tsumura & Co.

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 March 2011 in Cellular and Molecular Neurobiology
Verified
Journal Article
Closed access
PDF file
SISachiko Imamura
Sachiko Imamura
MTMasahiro Tabuchi
Masahiro Tabuchi
HKHirotaka Kushida
Hirotaka Kushida
ANAkinori Nishi
Akinori Nishi
HKHitomi Kanno
Hitomi Kanno
YKYoshio Kase
Yoshio Kase

20 March 2020 in Nutrients
Verified
Journal Article
Open access
PDF file
MNMitsue Nishiyama
Mitsue Nishiyama
NONobuhiro Ohtake
Nobuhiro Ohtake
AKAtsushi Kaneko
Atsushi Kaneko
NTNaoko Tsuchiya
Naoko Tsuchiya
SISachiko Imamura
Sachiko Imamura
TKToru Kono
Toru Kono
Non-alcoholic fatty liver disease (NAFLD) is considered a worldwide healthcare problem that mirrors the increased prevalence of obesity. Gut microbiota plays a crucial role in the progression and treatment of NAFLD. Bofutsushosan (BTS), a pharmaceutical-grade Japanese traditional medicine, has long been prescribed in Japan for obesity and obesity-related syndrome. Although BTS has been reported to exert an anti-obesity effect in obese patients as well as various obesity-model animals, its effect on gut microbiota is unknown. Here, the effects of BTS on obesity, liver damage, and the gut microbiome in genetically obese mice, ob/ob, were studied. Seven-week-old ob/ob mice were fed a standard diet with (BTS group) or without (CONT group) 5% BTS for 4 weeks. By comparison to the CONT group, the BTS group showed reduced body weight gain and hyperlipidemia as well as improved liver function. Moreover, gut microbiota in the CONT and BTS group formed a significantly different cluster. Specifically, the genera Akkermansia, Bacteroides and an unknown genus of the family Enterobacteriaceae expanded dramatically in the BTS group. Noteworthy, the population of Akkermansia muciniphila, which is reported to elicit an anti-obesity effect and improve various metabolic abnormalities, was markedly increased (93-fold) compared with the CONT group. These results imply that BTS may be a promising agent for treating NAFLD.

26 April 2008 in BMC Genomics
Verified
Journal Article
Open access
PDF file
KMKaori Munakata
Kaori Munakata
MYMasahiro Yamamoto
Masahiro Yamamoto
NANaoko Anjiki
Naoko Anjiki
MNMitsue Nishiyama
Mitsue Nishiyama
SISachiko Imamura
Sachiko Imamura
KWKenji Watanabe
Kenji Watanabe
Background: Although microbiota play a critical role in the normal development and function of host immune systems, the underlying mechanisms, especially those involved in the large intestine (LI), remain unknown. In the present study, we performed transcriptome analysis of the LI of germ-free (GF) and specific pathogen-free (SPF) mice of the IQI strain, an inbred strain established from ICR mice.Results: GeneChip analysis, quantitative real-time RT-PCR, and reconfirmation using bacteria-inoculated GF mice revealed differences in the expression levels of several immune-related genes, such as cryptdin-related sequences (CRS), certain subsets of type 1 interferon (IFN)-related genes, class Ib MHC molecules, and certain complements. LI expressed no authentic cryptdins but predominantly expressed CRS2, 4, and 7. The mRNA levels of IFN-related genes, including Irf7, Isgf3g, Ifit1 and Stat1, were lower in SPF- and flora-reconstituted mice. When an oral IFN-α inducer tilorone analog, R11567DA, was administered to SPF mice, IFN-α was induced rapidly in the LI at 4 h, whereas no IFN-α protein was detected in the small intestine (SI) or blood. In situ hybridization and immunohistochemistry suggested that the IFN-α production originated from Paneth cells in the SI, and portions of lamina proprial CD11b- or mPDCA1-positive cells in the LI.Conclusion: The present study suggests that microbial colonization, while inducing the expression of anti-microbial peptides, results in the down-regulation of certain genes responsible for immune responses, especially for type I IFN synthesis. This may reflect the adaptation process of the immune system in the LI to prevent excessive inflammation with respect to continuous microbial exposure. Further, the repertoire of anti-microbial peptides and the extraordinary role of interferon producing cells in the LI have been found to be distinct from those in the SI.

29 February 2008 in Surgery
Verified
Journal Article
Closed access
PDF file
YTYohei Tokita
Yohei Tokita
MYMitsutoshi Yuzurihara
Mitsutoshi Yuzurihara
KSKazuko Satoh
Kazuko Satoh
SISeiichi Iizuka
Seiichi Iizuka
SISachiko Imamura
Sachiko Imamura
STShuichi Takeda
Shuichi Takeda

1 November 2020 in Journal of Pharmacological Sciences
Verified
Journal Article
Open access
SISachiko Imamura
Sachiko Imamura
MTMasahiro Tabuchi
Masahiro Tabuchi
HOHiroaki Oizumi
Hiroaki Oizumi
TUToshiyuki Ueki
Toshiyuki Ueki
YOYuji Omiya
Yuji Omiya
KMKazushige Mizoguchi
Kazushige Mizoguchi
The traditional Japanese (Kampo) medicines yokukansan (YKS) and yokukansankachimpihange (YKSCH) have similar formulas and the same indications. In animals or cultured cells, the neuropharmacological actions of YKS are sometimes more beneficial than those of YKSCH. Since both drugs are used to treat sleep disorders in Japan, we examined the ameliorative effects of YKS and YKSCH on circadian rhythm disturbance and compared their efficacy using a mouse model of circadian rhythm disruption. Ramelteon was used as the positive control. Ramelteon treatment significantly reversed decreased running wheel activity during the advanced dark phase, indicating facilitation of circadian adaptation. YKS treatment also reversed the activity in the early period of drug treatment; however, it was not statistically significant. YKSCH treatment significantly reversed the decreased activity during the advanced dark phase. Plasma melatonin (MT) levels were significantly increased in the YKSCH but not in the YKS group. The ameliorative effect of YKSCH on rhythm disruption was significantly inhibited by coadministration of the MT2 receptor antagonist. Therefore, the therapeutic effect of YKSCH on circadian rhythm disruption would be attributable, to elevated endogenous MT levels. Taken together, YKS and YKSCH have different pharmacological properties and may be more precisely prescribed depending on patients' psychological symptoms.

1 April 2017 in Gastroenterology
Verified
Journal Article
Closed access
PDF file
MNMitsue Nishiyama
Mitsue Nishiyama
MYMasahiro Yamamoto
Masahiro Yamamoto
NONobuhiro Otake
Nobuhiro Otake
SISeiichi Iizuka
Seiichi Iizuka
SISachiko Imamura
Sachiko Imamura
TKToru Kono
Toru Kono